Assessment of the Safety and Efficacy of BRM421 Ophthalmic Solutions in Dry Eye Subjects.
Clinical trial NCT05695781 · COMPLETED
Trial details
- NCT number
- NCT05695781
- Sponsor
- BRIM Biotechnology Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-27
- Primary completion
- 2023-12-30
- Enrollment
- 740
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.